Saudat Adamson Fadeyi

Investor @Cancer Fund Impact Investments

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Aug 2025 — Present

Investor @Cancer Fund Impact Investments

View department →

Early-stage cancer investment fund focused on breakthrough science that transforms diagnosis, treatment, and management of cancer. Supporting pan-cancer platforms alongside high-impact, tumor-specific initiatives in Breast, Brain, Lung, Prostate, and Colorectal cancers, prioritizing strong scientific rationale, clear clinical pathways, and meaningful patient benefit.

EDUCATION

N/A

University of Rhode Island

MBA, Pharmaceutical Management

N/A

Rutgers University

B.Sc., Biological Science

N/A

Tennessee State University

Ph.D., Cancer Biology

SKILLS

Drug DiscoveryBiotechnologyStatisticsAnalytical ChemistryCell BiologyToxicologyImmunohistochemistryData AnalysisAnimal ModelsScienceBiochemistryImmunologyLifesciencesClinical ResearchWestern BlottingProject ManagementPharmacologyCell CultureCancerHplcCancer ResearchProtein ChemistryMicrobiologyInfectious DiseasesResearchLife SciencesGeneticsPcrClinical TrialsPharmaceutical IndustryMolecular BiologyCellScientific WritingMedical Writing

ABOUT SAUDAT ADAMSON FADEYI

Expertise in Innovation & Biotechnology, Cell & Gene Therapy, Drug Delivery, Drug Development, Oncology, Neurology, In/Out licensing, M&A, Pre-seed/Seed Investment, Venture Capital, Healthcare, Business development, Corporate Investment Strategy, Start-up Advisory, Diversity in Clinical Trials, Equity in Health Research, DEI Advocacy

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.